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Background: Telomere dysfunction is important in carcinogenesis, and recently, stathmin and elongation factor 1α
(EF1α) were reported to be up-regulated in telomere dysfunctional mice.
Methods: In the present study, the expression levels of stathmin and EF1α in relation to telomere length, telomere
dysfunction-induced foci (TIF), γ-H2AX, and p21WAF1/CIP1 expression were assessed in specimens of hepatitis B virus
(HBV)-related multistep hepatocarcinogenesis, including 13 liver cirrhosis specimens, 14 low-grade dysplastic nodules
(DN), 17 high-grade DNs, and 14 hepatocellular carcinomas (HCC). Five normal liver specimens were used as controls.
TIF were analyzed by telomere fluorescent in situ hybridization (FISH) combined with immunostaining, while the protein
expressions of stathmin, EF1α, γ-H2AX, and p21WAF1/CIP1 were detected by immunohistochemistry.
Result: The expressions of stathmin and EF1α gradually increased as multistep hepatocarcinogenesis progressed,
showing the highest levels in HCC. Stathmin mRNA levels were higher in high-grade DNs than normal liver and liver
cirrhosis, whereas EF1α mRNA expression did not show such a difference. The protein expressions of stathmin and
EF1α were found in DNs of precancerous lesions, whereas they were absent or present at very low levels in normal liver
and liver cirrhosis. Stathmin histoscores were higher in high-grade DNs and low-grade DNs than in normal liver (all,
P < 0.05). EF1α histoscores were higher in high-grade DNs than in normal liver and liver cirrhosis (all, P < 0.05). Stathmin
mRNA levels and histoscores, as well as EF1α histoscores (but not mRNA levels), were positively correlated with telomere
shortening and γ-H2AX labeling index (all, P < 0.05). EF1α histoscores were also positively correlated with TIF (P < 0.001).
Significantly greater inactivation of p21WAF1/CIP1 was observed in low-grade DNs, high-grade DNs, and HCC, compared to
liver cirrhosis (all, P < 0.05). p21WAF1/CIP1 labeling index was inversely correlated with TIF, stathmin mRNA level, and EF1α
histoscore (all, P < 0.05).
Conclusion: Stathmin and EF1α are suggested to be closely related to telomere dysfunction, DNA damage, and
inactivation of p21WAF1/CIP1 in HBV-related multistep hepatocarcinogenesis. Accordingly, assessment of stathmin and
EF1α levels as a reflection of telomere dysfunction may be helpful in evaluating the biological characteristics of
precancerous hepatic nodules in hepatitis B viral cirrhotic patients.
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Hepatocellular carcinoma (HCC) is reported as the fifth
most common cancer worldwide and the third most com-
mon cause of cancer-related deaths [1]. Hepatocarcinogen-
esis is a multistep process, and has been characterized as
the progressive accumulation of genetic and molecular
changes in chronic liver disease, which leads to the produc-
tion of monoclonal populations of dysplastic or trans-
formed hepatocytes. Mutations that impair the DNA
damage response pathways facilitate the survival of
dysplastic cells with shortened and dysfunctional telo-
meres, leading to the proliferation of cells with dicen-
tric chromosomes and the accumulation of genomic
instability due to breakage-fusion-bridge cycles. In fact,
chromosomal instability is characteristic of hepatitis B
virus (HBV)-related hepatocarcinogenesis [2]. Liver cir-
rhosis, a soil for HCC, is characterized by an increase in
dysplastic hepatocytes that form dysplastic foci or dys-
plastic nodules (DNs). Nevertheless, while DNs are con-
sidered precancerous lesions of HCC [3], various natural
outcomes of DNs have been reported [4,5].
Previously, expression of stathmin and elongation fac-
tor 1α (EF1α) was reported to be up-regulated in telo-
mere dysfunctional mice [6]. Stathmin, encoded by the
human STMN1 gene, is a major microtubule depolymer-
izing protein involved in cell cycle progression [7]. Stath-
min directly interacts with soluble tubulin to form a
complex that sequesters free tubulin and hinders the
polymerization of microtubules [8]. In mitosis, stathmin is
inactivated by phosphorylation to induce microtubule
polymerization and the assembly of mitotic spindles; phos-
phorylated stathmin is reactivated by dephosphorylation,
allowing cells to exit mitosis and enter a new interphase
[9]. Stathmin, also known as oncoprotein 18, has been re-
ported in several studies to be highly expressed in a wide
variety of human cancers, including leukemia, breast, pros-
tate, gastric, and liver cancer, suggesting that stathmin is a
key molecule in tumorigenesis [10-13]. Moreover, stathmin
overexpression in HCC reportedly increased the malignant
potential thereof by regulating cell motility, cell migration,
and cell proliferation [12]. Stathmin overexpression in
HCC was also shown to be correlated with poor prognosis
[14,15]. EF1α is a translational cofactor of eukaryotic pro-
tein synthesis that is important in the elongation of poly-
peptides. EF1α carries aminoacyl-tRNA to ribosomes and
dissociates after correct codon-anticodon recognition by
GTP hydrolysis [16]. Overexpression of EF1α in human
and rodent cells was reported to be associated with
increased cell proliferation, oncogenic transformation, and
delayed cell senescence [17]. A previous functional study
showed that EF1α interacts with p-Akt to control the
activity of p-Akt and regulates the proliferation, survival,
and motility of breast cancer cells [18]. Additionally,
increased expression of EF1α was reported to be associatedwith the growth rate of an HCC cell line, but not with
apoptosis [19].
The assessment of telomere dysfunction may be helpful
in evaluating the biological characteristics of hepatic
nodules in cirrhotic patients. However, systemic assess-
ment of the expression levels of stathmin and EF1α in rela-
tion to telomere dysfunction, particularly telomere length
and telomerase dysfunction induced foci (TIF), has not
been conducted in defined lesions of human multistep
hepatocarcinogenesis, including DNs. Accordingly, the
present study attempted to evaluate and compare the
expression levels of stathmin and EF1α in relation to telo-
mere length, TIF, γ-H2AX, and p21WAF1/CIP1 expression in
human HBV-associated multistep hepatocarcinogenesis.
Materials and methods
Tissue samples and pathological examination
A total of 58 liver specimens from 24 patients were investi-
gated, including 13 cases of liver cirrhosis, 14 cases of low-
grade DNs, 17 cases of high-grade DNs, and 14 cases of
HCC. The specimens were obtained from 19 men and five
women whose ages ranged from 32 to 63 years (51 ±
7.8 years, mean ± SD). They were all serum HBsAg-
positive and anti-HCV-negative. The clinicopathological
features of the patients are summarized in Table 1. Large
nodules, measuring at least 0.5 cm at their largest dimen-
sion, that were apparently distinct from the surrounding
cirrhotic parenchyma, in terms of their color, texture, and
degree of bulging at the cut surface; HCCs; and corre-
sponding non-neoplastic liver tissue were collected. Half of
each nodule was fixed in 10% buffered formalin, routinely
processed, and embedded in paraffin for histological
examination. The remaining half of each nodule was snap-
frozen in liquid nitrogen and stored at −80°C until ready
for use. Hepatocellular nodules were evaluated according
to the criteria proposed by the International Consensus
Group for Hepatocellular Neoplasia [3]. Differentiation of
HCC was determined on the basis of Edmonson and
Steiner classification [20]. For comparison, non-neoplastic
liver tissues were obtained from 5 patients with metastatic
carcinoma. Control subjects were negative for hepatitis
virus and showed relatively normal liver histology. The
ages of the controls ranged from 42 to 74 years (61 ±
13.9 years). Fresh frozen specimens were obtained from
the Liver Cancer Specimen Bank (part of the National
Research Bank Program, Korea Science and Engineering
Foundation, Ministry of Science and Technology). This
study was approved by the Institutional Review Board of
Severance Hospital, Yonsei University College of Medicine,
and the requirement for informed consent was waived.
Total RNA extraction and real-time quantitative RT-PCR
Total RNA was isolated from human fresh frozen liver tis-
sue samples using TRIzol reagent (Invitrogen, Carlsbad,
Table 1 Clinical and pathological findings of the patients
Case no Age Sex Etiology Pathological diagnosisa
1 44 F HBV LC, LGDN, HGDN, HGDN, HCC (2)
2 52 M HBV LC, LGDN, HGDN, HGDN, HGDN, HGDN, HCC (2), HCC (2)
3 60 F HBV LC, HGDN, HGDN, HCC (1)
4 48 M HBV LC, HGDN, HGDN, HCC (1)
5 49 M HBV LC, LGDN, LGDN, LGDN, LGDN, LGDN, LGDN, HCC (3)
6 53 F HBV LGDN, HGDN
7 53 M HBV LGDN, HGDN
8 45 M HBV LC, HGDN
9 60 M HBV LC, HGDN
10 59 M HBV LC, HGDN
11 32 F HBV LC, LGDN
12 48 M HBV LC, LGDN, LGDN
13 59 M HBV LC, HCC (1),
14 56 M HBV HCC (3)
15 41 M HBV HCC (3)
16 43 M HBV HCC (3)
17 40 M HBV HCC (2)
18 60 M HBV HCC (2)
19 54 F HBV HCC (2)
20 49 M HBV HCC (2)
21 51 M HBV LGDN
22 63 M HBV HGDN, HGDN
23 48 M HBV LC
24 48 M HBV LC
M, male; F, female; HBV, hepatitis B virus; LGDN, low-grade dysplastic nodule; HGDN, high-grade dysplastic nodule; HCC, hepatocellular carcinoma.
aHCC grading according to the Edmondson and Steiner classification is in parentheses.
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formed using a High Capacity RNA-to-cDNA kit (Applied
Biosystems, Foster City, CA, USA). The following TaqMan
Gene Expression Assays were purchased from Applied Bio-
systems: EF1α (Hs00265885_g1), stathmin (Hs01027
516_g1), and GAPDH (Hs99999905_m1). All measure-
ments were performed in triplicate. The relative expression
levels of target mRNAs were normalized to GAPDH
mRNA levels.
PCR was performed in triplicate for each cDNA sample
using the ABI PRISM 7300 Sequence Detection System
(Applied Biosystems). Dual-labeled FAM probes contain-
ing a 5′-fluorescent reporter and a 3′- quencher were
used to conduct the PCR experiments.Immunohistochemical analysis of stathmin, EF1α,
p21WAF1/CIP1, and γ-H2AX
Immunohistochemical staining was performed to detect
the expression levels of stathmin, EF1α, p21WAF1/CIP1,
and γ-H2AX, as previously described [2]. Details on theantibodies used and antigen-retrieval conditions are
summarized in Additional file 1: Table S1.
The staining intensities of stathmin and EF1α were
graded on a scale of 0–3 (0, negative; 1, weakly positive; 2,
moderately positive; and 3, strongly positive), and the
extent of distribution was rated on a scale of 0–4 (0, posi-
tive in <5% of cells; 1, 5-25%; 2, 26-50%; 3, 51-75%; and 4,
76 ~ 100%). Histoscore was defined as the sum of the in-
tensity and distribution scores. For interpretation of the
immunohistochemical stain results for γ-H2AX, dark
brown stained nuclei were counted as being positive for
antibody, and labeling indices were determined as follows:
(number of positive hepatocytic nuclei in five randomly
selected fields at × 400 magnification)/(total number of
hepatocytic nuclei) × 100%.
Telomere terminal restriction fragment length analysis
Telomere terminal restriction fragments were measured
as previously described [2]. Briefly, telomere length was
measured by Southern blotting. Two μg of digested DNA
was separated on 0.7% agarose gel. Hybridization was
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Molecular Biochemicals, Mannheim, Germany) and de-
tected as recommended by the manufacturer. The result-
ing X-ray film was scanned with a luminescent image
analyzer (Fujifilm, Tokyo, Japan), and the telomere signals
in each lane were quantified as a grid object, defined as a
single column with 25 rows, using Image Gauge Software
2.54 (Fujifilm).
Telomere fluorescent in situ hybridization (FISH)
combined immunostaining for γ-H2AX
TIF were detected in representative sections of formalin-
fixed paraffin-embedded tissues by staining for γ-H2AX
and by telomere in situ hybridization using a telomere-
specific peptide nucleic acid probe (Cy3-(CCCTAA)3;
Panagene, Daejeon, Korea). Tissue sections were depar-
affinized and then rehydrated with graded alcohol. After
incubation in 0.2 N HCl for 20 min, slides were boiled
in 10 mM citrate buffer, pH 6.0, for 15 min to retrieve
antigens. Sections were then treated with protease solu-
tion (Abbott Molecular Inc, Des Plaines, IL, USA) and
fixed. Sections were dehydrated in 100% ethanol for
5 min. After air-drying, slides were applied 10 μL of a
telomere peptide nucleic acid probe mixture (70% form-
amide deionized, 5 mM Tris–HCl, pH 7.4, 1 mM MgCl2,
0.45 mM Citric acid, 4.1 mM NaHPO4, 0.1 μg telomere-
specific peptide nucleic acid probe, 5% blocking reagent
[Roche Molecular Biochemicals]), denatured at 80°C for
3 min, and hybridized at 30°C for 2 hrs. Slides were then
washed sequentially with 0.6X SSC/70% formamide
(90 mM NaCl, 9 mM Na-citrate [pH 7.0]; 3 × 15 min), 2X
SSC (2 × 15 min), PBS (1 × 5 min), and PBST (PBS + 0.1%
Tween 20:15 min), and then blocked with 5% BSA for
5 min. Immunostaining using primary polyclonal anti-γ-
H2AX (1:500; Novus Biologicals, Littleton, CO, USA) and
secondary Alexa Fluor 488-conjugated goat anti rabbit
antibody (1:1,000; Invitrogen) was performed.
Statistical analysis
Statistical analysis was conducted using SPSS (version
18.0.0; SPSS Inc., Chicago, IL, USA) and R package soft-
ware (version 3.0.2; http://www.R-project.org), applying
the Mann–Whitney test, Spearman’s correlation coeffi-
cient, linear model, and log linear model as deemed
appropriate. Significance was set at P < 0.05 for all tests.
Results
Stathmin expression in HBV-related multistep
hepatocarcinogenesis
The mRNA levels of stathmin were 0.3 ± 0.12 (mean ± SD)
(range, 0.2 ~ 0.5) in normal liver, 0.5 ± 0.61 (0.1 ~ 2.1) in
liver cirrhosis, 0.8 ± 0.57 (0.1 ~ 2.0) in low-grade DNs,
1.5 ± 1.29 (0.1 ~ 4.7) in high-grade DNs, and 2.3 ± 1.95
(0.4 ~ 7.0) in HCC. Stathmin mRNA levels graduallyincreased as multistep hepatocarcinogenesis progressed
from normal liver, low-grade DNs, and high-grade DNs to
HCC, which showed the highest level of expression and
statistical significance (P for trend < 0.001) (Figure 1A).
The differences in mRNA levels were statistically signifi-
cant between normal liver and high-grade DNs, as well as
between liver cirrhosis and high-grade DNs (all, P < 0.05).
Stathmin mRNA levels in HCC were significantly higher
than those in normal liver, liver cirrhosis, and low-grade
DNs (all, P < 0.05).
Similarly, the expression of stathmin protein also gradually
increased as multistep hepatocarcinogenesis progressed to-
wards HCC (P for trend < 0.001) (Figure 1B, Figure 2B).
Most normal liver specimens showed no expression of
stathmin protein, except for one case that showed weak
expression of histoscore grade 1. The mean histoscores
for stathmin were 1.3 ± 0.63 in liver cirrhosis, 2.0 ± 1.57
in low-grade DNs, 2.6 ± 2.12 in high-grade DNs, and
4.1 ± 1.77 in HCC. Stathmin histoscores were signifi-
cantly different between liver cirrhosis and HCC, as
well as between low-grade DNs and HCC; moreover,
stathmin histoscores were significantly greater in liver
cirrhosis, low-grade DNs, high-grade DNs, and HCC
than in normal liver (all, P < 0.05).
EF1α expression in HBV-related multistep
hepatocarcinogenesis
The mRNA levels of EF1α were 2.9 ± 0.71 (mean ± SD)
(range, 2.3 ~ 4.0) in normal liver, 1.9 ± 0.83 (0.2 ~ 3.2) in
liver cirrhosis, 1.6 ± 0.74 (0.3 ~ 3.1) in low-grade DNs,
2.5 ± 1.76 (0.9 ~ 8) in high-grade DNs, and 3.9 ± 3.19
(1.1 ~ 13.2) in HCC (Figure 1C). HCC showed the highest
level of EF1α mRNA expression, which was significantly
higher than that in low-grade DNs (P = 0.009), whereas
liver cirrhosis and low-grade DNs showed lower levels of
EF1α mRNA expression than normal liver (P < 0.05 for
both). The mRNA expression of EF1α showed significant
increases as multistep hepatocarcinogenesis progressed
towards HCC (P for trend = 0.035).
EF1α protein was not expressed in normal liver, but
was detected in dysplastic and HCC cells (Figure 2C).
The histoscores of EF1α protein were 0.2 ± 0.55 (mean ±
SD) (range, 0 ~ 2) in liver cirrhosis, 0.7 ± 1.14 (0 ~ 4) in
low-grade DNs, 1.3 ± 1.36 (0 ~ 5) in high-grade DNs,
and 2.4 ± 1.87 (1 ~ 7) in HCC (Figure 1D), and gradually
increased from liver cirrhosis, low-grade DNs, high-
grade DNs to HCC with statistical significance (P for
trend < 0.001). HCC showed the highest EF1α histoscore,
which was significantly higher than that for low-grade
DNs, liver cirrhosis and normal liver (all, P < 0.05). EF1α
histoscores were also significantly greater in high-grade
DNs than in liver cirrhosis (P = 0.002) and normal liver
(P = 0.013). The histoscores of EF1α and stathmin were
shown to be positively correlated (P < 0.001, R = 0.443),
Figure 1 Expression levels of stathmin and elongation factor 1α (EF1α) in HBV-related multistep hepatocarcinogenesis. Box plots show
expression levels of stathmin mRNA (A), stathmin protein (B), EF1α mRNA (C), and EF1α protein (D). ‡ Statistical significance (linear trend model,
P < 0.05) *Statistical significance (P < 0.05). NL, normal liver; LC, liver cirrhosis; LGDN, low-grade dysplastic nodules; HGDN, high-grade dysplastic
nodules; HCC, hepatocellular carcinoma.
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significant correlation (P = 0.558, R = 0.075).Telomere length and its relationship with stathmin and
EF1α expression in HBV-related multistep
hepatocarcinogenesis
Telomere length gradually decreased as multistep hepato-
carcinogenesis progressed towards HCC, with statistical
significance (P for trend = 0.032); part of this data was pre-
viously reported [2]. Telomere lengths were 8.5 ± 0.92
(mean ± SD) (range, 7.3 ~ 9.3) in normal liver, 7.6 ± 1.81
(4.6 ~ 11.3) in liver cirrhosis, 6.4 ± 1.63 (4.7 ~ 10.2) in low-
grade DNs, 6.8 ± 2.54 (2.9 ~ 11.5) in high-grade DNs, and
6.3 ± 2.19 (3.4 ~ 10.7) in HCC (Figure 3A).
Next, the associations of telomere length with stath-
min and EF1α expression were evaluated. Both mRNA
levels and histoscores for stathmin showed significant
negative correlations with telomere length (Figure 3B
and C) (P= 0.004, R = −0.353 and P = 0.029, R = −0.276, re-
spectively). EF1α histoscore showed a significant negative
correlation with telomere length (P= 0.001, R = −0.404)
(Figure 3D), whereas EF1α mRNA level showed no signifi-
cant correlation with telomere length (P = 0.719, R = −0.046)
(Additional file 2: Figure S1A).γ-H2AX expression and its relationship with stathmin and
EF1α expression and telomere length in HBV-related
multistep hepatocarcinogenesis
To evaluate DNA damage in multistep hepatocarcinogen-
esis, immunohistochemical analysis of γ-H2AX was per-
formed. The expression of γ-H2AX protein was detected
in the nuclei of dysplastic and neoplastic cells. The γ-
H2AX labeling indices were 1.3 ± 4.13 (mean ± SD) (range,
0 ~ 15.0) in liver cirrhosis, 2.4 ± 5.67 (0 ~ 21.3) in low-
grade DNs, 4.1 ± 10.42 (0 ~ 40.2) in high-grade DNs, and
10.3 ± 17.00 (0 ~ 49.0) in HCC (Figure 4A). γ-H2AX label-
ing index showed a gradual increase from liver cirrhosis,
low-grade DNs, and high-grade DNs to HCC with statis-
tical significance (P for trend = 0.016) . γ-H2AX labeling
index in HCC was significantly higher than that in normal
liver, liver cirrhosis, low-grade DNs, and high-grade DNs
(all, P < 0.05). Additionally, γ-H2AX labeling index showed
a significant negative correlation with telomere length
(P = 0.018, R = −0.300); higher expression of γ-H2AX
labeling index was found in lesions with shorter telo-
mere lengths (Figure 4B).
The associations between γ-H2AX labeling index and
the expression levels of stathmin and EF1α were further
analyzed. γ-H2AX labeling index showed a significant posi-
tive correlation with both mRNA levels and histoscores of
Figure 2 Representative immunohistochemical features of stathmin, elongation factor 1α (EF1α) and p21WAF1/CIP1 in HBV-related
multistep hepatocarcinogenesis. Representative pathological features of normal liver (NL), liver cirrhosis (LC), low-grade dysplastic nodules
(LGDN), high-grade dysplastic nodules (HGDN), and hepatocellular carcinoma (HCC) are presented in the upper panel (A). Immunohistochemical
findings of stathmin (B), EF1α (C) and p21WAF1/CIP1 (D) for each type of lesion are shown, respectively (Original magnification × 200). Inset, higher
power magnification of EF1α and p21WAF1/CIP1 (×400).
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respectively), indicating that an increase in stathmin
expression is associated with DNA damage (Figure 4C and
D). For EF1α expression, histoscores of EF1α protein
showed a positive correlation with γ-H2AX index (P <
0.003, R = 0.373) (Figure 4D); however, we observed no
significant correlations between EF1α mRNA level and γ-
H2AX labeling index (P = 0.555, R = −0.076) (Additional
file 2: Figure S1B).
Telomere dysfunction induced foci (TIF) and their
relationship with stathmin and EF1α expression in
HBV-related multistep hepatocarcinogenesis
In order to determine the fractions of TIF during human
multistep hepatocarcinogenesis, we performed telomere
FISH combined with immunostaining for anti-γ-H2AX
to detect colocalization of telomeres and γ-H2AX foci
(Figure 5A). A gradual increase of TIF was observed as
multistep hepatocarcinogenesis progressed towards HCC
with statistical significance (P for trend < 0.01) (Figure 5B).
Normal liver showed the lowest average number of TIF, 0.1
± 0.30 (mean ± SD) (range, 0.06 ~ 0.16), and the number of
TIF gradually increased as multistep hepatocarcinogenesisprogressed from normal liver, liver cirrhosis, low-grade
DNs, and high-grade DNs to HCC (liver cirrhosis; 0.1 ± 0.06
[0.06 ~ 0.21], low-grade DNs; 0.3 ± 0.23 [0.06 ~ 0.69], high-
grade DNs; 0.4 ± 0.12 [0.26 ~ 0.76], HCC; 0.8 ± 0.48 [0.24 ~
1.56]). HCC showed a significantly higher number of TIF,
compared to normal liver, liver cirrhosis, and low-grade
DNs (all, P < 0.05); high-grade DNs showed a significantly
higher number of TIF, compared to normal liver and liver
cirrhosis (all, P < 0.05); and low-grade DNs showed a signifi-
cantly higher number of TIF than normal liver (P= 0.048).
We further analyzed the relationships between TIF and
telomere length, as well as TIF and the protein expres-
sion levels of stathmin and EF1α. TIF showed a signifi-
cant negative correlation with telomere length (P =
0.020, R = −0.415, Figure 5C). EF1α histoscore showed
a significant positive correlation with TIF, suggesting
that higher EF1α expression is associated with a greater
number of TIF, indicating increased telomere dysfunc-
tion (P < 0.001, R = 0.602) (Figure 5D). Stathmin histo-
score, however, showed no significant correlation with
TIF (P = 0.326, R = 0.182) (Additional file 2: Figure
S1C). We also observed no significant correlations be-
tween TIF and the mRNA levels of both stathmin and
Figure 3 Telomere length and the correlations thereof with stathmin and elongation factor 1α (EF1α) expression in HBV-related
multistep hepatocarcinogenesis. A. Telomere terminal restriction fragment (TRF) length in normal liver (NL), liver cirrhosis (LC), low-grade
dysplastic nodules (LGDN), high-grade dysplastic nodules (HGDN), and hepatocellular carcinoma (HCC). B-C. Correlation between TRF length and
stathmin mRNA (B) and stathmin protein levels (C). D. Correlation between TRF length and EF1α protein levels. ‡ Statistical significance (linear
trend model, P < 0.05). *Statistical significance (P < 0.05).
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p21WAF1/CIP1 labeling index and its relationship with TIF,
and stathmin and EF1α expression in HBV-related multistep
hepatocarcinogenesis
The expression of p21WAF1/CIP1 protein was investigated
in multistep hepatocarcinogenesis; part of the data was
previously reported [2]. The p21WAF1/CIP1 labeling indi-
ces showed gradual statistically significant decreases as
multistep hepatocarcinogenesis progressed towards HCC
(P for trend = 0.002) (Figure 2D and Figure 6A).
The p21WAF1/CIP1 labeling indices were 10.4 ± 6.09
(mean ± SD) (range, 3.1 ~ 18.6) in normal liver, 24.9 ±
13.55 (1.6 ~ 47.2) in liver cirrhosis, 7.9 ± 2.90 (2.7 ~ 11.2)
in low-grade DNs, 11.0 ± 11.11 (0.8 ~ 44.7) in high-grade
DNs, and 5.9 ± 8.08 (0.4 ~ 30.2) in HCC. p21WAF1/CIP1
labeling index was highest in liver cirrhosis, which wassignificantly higher than that in normal liver, low-grade
DNs, high-grade DNs, and HCC (all, P < 0.05). The
p21WAF1/CIP1 labeling index of HCC was the lowest, and
was significantly lower than that in low-grade DNs,
high-grade DNs, and liver cirrhosis (all, P < 0.05).
p21WAF1/CIP1 labeling index showed a significant nega-
tive correlation with TIF (P = 0.045, R = −0.362) (i.e.,
higher TIF was correlated with lower p21WAF1/CIP1la-
beling index) (Figure 6B). Additionally, associations
between p21WAF1/CIP1 labeling index and the expression
levels of stathmin and EF1α were analyzed. Both stath-
min mRNA levels and histoscores showed a negative
correlation with p21WAF1/CIP1labeling index (Figure 6C
and D) (P = 0.008, R = −0.333, and P = 0.05, R = −0.248,
respectively) (i.e., higher stathmin expression was corre-
lated with lower p21WAF1/CIP1labeling index). EF1α
histoscore showed a significant negative correlation with
p21WAF1/CIP1labeling index, as higher EF1α histoscores
Figure 4 Expression of γ-H2AX and its correlation with telomere length, stathmin and elongation factor 1α (EF1α) expression in
HBV-related multistep hepatocarcinogenesis. A. γ-H2AX labeling index in normal liver (NL), liver cirrhosis (LC), low-grade dysplastic nodules
(LGDN), high-grade dysplastic nodules (HGDN), and hepatocellular carcinoma (HCC). ‡ Statistical significance (linear trend model, P < 0.05). B. Correlation
between γ-H2AX labeling index and telomere length. C-D. Correlation between γ-H2AX labeling index and stathmin mRNA (C) and stathmin protein
level (D). E. Correlation between γ-H2AX labeling index and EF1α protein levels (F). *Statistical significance (P < 0.05).
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(P < 0.001, R = −0.486), whereas EF1α mRNA levels
showed no significant correlation with p21WAF1/CIP1la-
beling index (P = 0.383, R = −0.112) (Figure 6E and
Additional file 2: Figure S1D).
Discussion
Telomere erosion occurs in proliferating cells with insuffi-
cient telomerase activity; thereby, critically short telomeres
become dysfunctional and trigger apoptosis and/or senes-
cence as a tumor suppressive mechanism. Meanwhile,
mutations that impair the DNA damage response path-
ways allow for survival of cells with critically short telo-
meres. As a result, cells with dicentric chromosomes can
proliferate and lead to the accumulation of genomic
instability due to breakage-fusion-bridge cycles. In the
present study, a gradual increase in shortened and
dysfunctional telomeres was found as HBV-related multi-
step hepatocarcinogenesis progressed to HCC. Low-grade
DNs showed a significantly higher number of TIF thannormal liver; high-grade DNs exhibited a significantly
greater number of TIF than liver cirrhosis and normal
liver; and HCC showed the highest number of dys-
functional telomeres. Additionally, telomere length was
inversely correlated with γ-H2AX labeling index, a DNA
damage marker. These findings support that telomere
dysfunction and DNA damage are important in the pro-
gression of HBV-related multistep hepatocarcinogenesis.
Stathmin was recently shown to be induced in response
to telomere dysfunction and DNA damage in human
aging and diseases [6]. Excessive stathmin activity was
reported to generate chromosomal instability through
blockage, subsequent to metaphase-to-anaphase transi-
tion, by decreasing the fidelity of chromosome segregation
to spindle poles during anaphase in an in vitro study [21].
In the present study, stathmin expression at both the
mRNA and protein level increased gradually as multistep
hepatocarcinogenesis progressed from liver cirrhosis, low-
grade DNs, and high-grade DNs to HCC, which showed
the highest levels of expression. Interestingly, stathmin
Figure 5 Telomere dysfunctional induced foci (TIF) in HBV-related multistep hepatocarcinogenesis and the correlations thereof with
stathmin and elongation factor 1α (EF1α) expression. A. Representative features of colocalization of γ-H2AX and telomeric DNA in defined
lesions of human multistep hepatocarcinogenesis. TIF are indicated by colored arrowheads: blue, DAPI; green, γ-H2AX; red, telomeres; yellow, TIF.
B. Box plots show fractions of TIF-positive cells in normal liver (NL), liver cirrhosis (LC), low-grade dysplastic nodules (LGDN), high-grade dysplastic
nodules (HGDN), and hepatocellular carcinoma (HCC). ‡ Statistical significance (linear trend model, P < 0.05). C. Correlation between TIF and TRF
length. D. Correlation between TIF and histoscore EF1α. *Statistical significance (P < 0.05).
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than in liver cirrhosis and normal liver and the histoscores
of stathmin protein were higher in high-grade DNs and
low-grade DNs than normal liver; stathmin expression
was not detected in normal liver. Additionally, the protein
and mRNA expression levels of stathmin were well corre-
lated with γ-H2AX labeling index and telomere shorten-
ing; moreover, fractions of TIF-positive cells were also
well correlated with telomere length shortening.
The primary function of EF1α is to transport aminoacyl-
tRNA to ribosomes during protein translation. Theoverexpression of EF1α was previously reported to be
associated with cell proliferation, oncogenic transform-
ation, and delayed cell senescence in human and rodent
cells [16,17]. As well, previous functional studies demon-
strated that EF1α regulates the proliferation, survival, and
motility of breast cancer cells [18] and induces higher pro-
liferation capacity in undifferentiated HCC cell lines [19].
In the present study, EF1α protein expression gradually
increased in human multistep hepatocarcinogenesis, and
was highest in HCC. Interestingly, EF1α histoscore in
HGDN was significantly higher than that in normal liver
Figure 6 p21WAF1/CIP1 labeling index in HBV-related multistep hepatocarcinogenesis and the correlations thereof with stathmin and
elongation factor 1α (EF1α) expression. A. Box plots show p21WAF1/CIP1 labeling index in normal liver (NL), liver cirrhosis (LC), low-grade dysplastic
nodules (LGDN), high-grade dysplastic nodules (HGDN), and hepatocellular carcinoma (HCC). ‡ Statistical significance (linear trend model, P < 0.05).
B. Correlations between p21WAF1/CIP1 labeling index and TIF. C-D. Correlations between p21WAF1/CIP1 labeling index and stathmin mRNA (C) and
stathmin protein levels (D). E. Correlations between p21WAF1/CIP1 labeling index and EF1α protein levels. *Statistical significance (P < 0.05).
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were well correlated with γ-H2AX labeling index and TIF,
whereas they exhibited a significant inverse correlation
with telomere length. Meanwhile, EF1α mRNA level
showed no significant correlation with telomere length, γ-
H2AX labeling index, TIF, or p21WAF1/CIP1 labeling index,
and further investigation of a translational regulation
mechanism for EF1α is needed. Notwithstanding, our data
suggested that the expression of stathmin and EF1α arises
in DNs as precancerous lesions and gradually increases
along with progression of human hepatocarcinogenesis,
suggesting that expression of stathmin and EF1α is in-
duced by shortened and dysfunctional telomeres in B viral
multistep hepatocarcinogenesis.
p21WAF1/CIP1 is a potent cyclin-dependent kinase
inhibitor and the expression of this gene is controlled by
the tumor suppressor protein p53, through which this
protein mediates the p53-dependent cell cycle G1 phase
arrest in response to a variety of stress stimuli [22]. In
this study, p21WAF1/CIP1 was inactivated in low-grade
DNs, high-grade DNs, and HCC, in contrast to its highexpression in liver cirrhosis. Interestingly, p21WAF1/CIP1 la-
beling index showed a significant negative correlation with
TIF, stathmin mRNA level, and the histoscores of EF1α
protein in this study. Accordingly, the p21WAF1/CIP1 cell
cycle check point was discerned to be a defense mechan-
ism against damaged and transformed cells, triggered by
dysfunctional telomeres in multistep hepatocarcinogenesis.
The natural history of DNs has not been fully clarified,
and prospective studies conducted in large series of
histologically proven non-neoplastic nodules detected by
ultrasonography during surveillance programs of cirrho-
sis have demonstrated a wide evolutionary fate for such
lesions. The hazard ratios of high-grade DNs, low-grade
DNs, and large regenerative nodules for transformation
to HCC were reported to be 16.8, 2.96, and 1.0, respect-
ively [4,5]. However, it is difficult to predict the bio-
logical behavior of individual hepatic nodules, as some
high-grade DNs remain stable for a long time period
and a few of them even disappear. Therefore, the assess-
ment of shortened and dysfunctional telomeres may be
helpful to evaluating biological characteristics of hepatic
Ahn et al. Journal of Translational Medicine 2014, 12:154 Page 11 of 12
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function using telomere FISH combined immunostaining
is very time consuming and labor intensive. Nevertheless,
this study revealed that the expressions of stathmin and
EF1α are good indicators of shortened and dysfunctional
telomeres, and the evaluation of the expression levels
thereof in conjunction with p21WAF1/CIP1 may prove help-
ful in characterizing the biological nature of hepatic nod-
ules in B viral cirrhotic patients.
Here, we demonstrated for the first time that the
expression of stathmin and EF1α are closely related to
telomere dysfunction, DNA damage, and inactivation of
p21WAF1/CIP1 in the defined lesions of HBV-related mul-
tistep hepatocarcinogenesis, including liver cirrhosis,
low-grade DNs, high-grade DNs, and HCC. Accordingly,
assessment of stathmin and EF1α levels as a reflection of
telomere dysfunction may be helpful in evaluating the
biological characteristics of precancerous hepatic nod-
ules in hepatitis B viral cirrhotic patients.
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Additional file 1: Table S1. Antibodies used in this study.
Additional file 2: Figure S1. Correlation of stathmin and elongation
factor 1α (EF1α) expression with telomere dysfunction and DNA damage
in HBV-related multistep hepatocarcinogenesis. A-B. Scatter plots reveal a
correlation between EF1α mRNA expression and telomere terminal
restriction fragment (TRF) length (A) and γ-H2AX labeling index (B). C.
Correlation between telomere dysfunction induced foci (TIF) and stathmin
protein level. D. Scatter plot of a correlation between p21WAF1/CIP1 labeling
index and EF1α mRNA expression.
Competing interests
All authors have no competing interest to disclose.
Author’s contributions
EY Ahn and JE Yoo designed the study and carried out experiments and
analysis of data and drafted manuscript. J Choi analyzed some part of the
data and participated in collection of human specimens. H Rhee, MS Kim, JE
Ko and JS Lee participated in collection of human specimens. YN Park
conceived of the study, participated in its design and coordination, and
helped to draft the manuscript. All authors read and approved the final
manuscript.
Acknowledgements
This study was supported by a grant from the Korea Health Technology R&D
Project through the Korea Health Industry Development Institute (KHIDI),
funded by the Ministry of Health & Welfare, Republic of Korea (grant number:
HI12C0555).
We would like to thank Anthony Milliken for his help with English editing.
We would also like to thank the Biostatistics Collaboration Unit, Yonsei
University College of Medicine, for their statistical assistance and Yonsei-Carl
Zeiss Advanced Imaging Center, Yonsei University College of Medicine, for
their technical assistance.
Author details
1Department of Pathology, Yonsei University College of Medicine, 250
Seongsan-ro, Seodaemun-gu, Seoul, South Korea. 2Brain Korea 21 PLUS
Project for Medical Science, Seoul, South Korea. 3Department of Pathology,
Wonju Christian Hospital, Wonju, South Korea. 4Department of Surgery,
Yonsei University College of Medicine, Seoul, South Korea. 5Severance
Biomedical Science Institute, Yonsei University College of Medicine, Seoul,South Korea. 6Integrated Genomic Research Center for Metabolic Regulation,
Yonsei University College of Medicine, Seoul, South Korea.
Received: 11 February 2014 Accepted: 27 May 2014
Published: 31 May 2014
References
1. Parkin DM, Bray F, Ferlay J, Pisani P: Global cancer statistics, 2002. CA
Cancer J Clin 2005, 55:74–108.
2. Lee YH, Oh BK, Yoo JE, Yoon SM, Choi J, Kim KS, Park YN: Chromosomal
instability, telomere shortening, and inactivation of p21(WAF1/CIP1) in
dysplastic nodules of hepatitis B virus-associated multistep
hepatocarcinogenesis. Mod Pathol 2009, 22:1121–1131.
3. International Consensus Group for Hepatocellular Neoplasia: Pathologic
diagnosis of early hepatocellular carcinoma: a report of the international
consensus group for hepatocellular neoplasia. Hepatology 2009,
49:658–664.
4. Borzio M, Fargion S, Borzio F, Fracanzani AL, Croce AM, Stroffolini T, Oldani
S, Cotichini R, Roncalli M: Impact of large regenerative, low grade and
high grade dysplastic nodules in hepatocellular carcinoma development.
J Hepatol 2003, 39:208–214.
5. Kobayashi M, Ikeda K, Hosaka T, Sezaki H, Someya T, Akuta N, Suzuki F,
Suzuki Y, Saitoh S, Arase Y, Kumada H: Dysplastic nodules frequently
develop into hepatocellular carcinoma in patients with chronic viral
hepatitis and cirrhosis. Cancer 2006, 106:636–647.
6. Jiang H, Schiffer E, Song Z, Wang J, Zurbig P, Thedieck K, Moes S, Bantel H,
Saal N, Jantos J, Brecht M, Jeno P, Hall MN, Hager K, Manns MP, Hecker H,
Ganser A, Dohner K, Bartke A, Meissner C, Mischak H, Ju Z, Rudolph KL:
Proteins induced by telomere dysfunction and DNA damage represent
biomarkers of human aging and disease. Proc Natl Acad Sci U S A 2008,
105:11299–11304.
7. Rubin CI, Atweh GF: The role of stathmin in the regulation of the cell
cycle. J Cell Biochem 2004, 93:242–250.
8. Charbaut E, Curmi PA, Ozon S, Lachkar S, Redeker V, Sobel A: Stathmin
family proteins display specific molecular and tubulin binding
properties. J Biol Chem 2001, 276:16146–16154.
9. Curmi PA, Gavet O, Charbaut E, Ozon S, Lachkar-Colmerauer S, Manceau V,
Siavoshian S, Maucuer A, Sobel A: Stathmin and its phosphoprotein family:
general properties, biochemical and functional interaction with tubulin.
Cell Struct Funct 1999, 24:345–357.
10. Curmi PA, Nogues C, Lachkar S, Carelle N, Gonthier MP, Sobel A, Lidereau R,
Bieche I: Overexpression of stathmin in breast carcinomas points out to
highly proliferative tumours. Br J Cancer 2000, 82:142–150.
11. Friedrich B, Gronberg H, Landstrom M, Gullberg M, Bergh A: Differentiation-
stage specific expression of oncoprotein 18 in human and rat prostatic
adenocarcinoma. Prostate 1995, 27:102–109.
12. Gan L, Guo K, Li Y, Kang X, Sun L, Shu H, Liu Y: Up-regulated expression of
stathmin may be associated with hepatocarcinogenesis. Oncol Rep 2010,
23:1037–1043.
13. Jeon TY, Han ME, Lee YW, Lee YS, Kim GH, Song GA, Hur GY, Kim JY, Kim
HJ, Yoon S, Baek SY, Kim BS, Kim BJ, Oh SO: Overexpression of stathmin1
in the diffuse type of gastric cancer and its roles in proliferation and
migration of gastric cancer cells. Br J Cancer 2010, 102:710–718.
14. Singer S, Ehemann V, Brauckhoff A, Keith M, Vreden S, Schirmacher P,
Breuhahn K: Protumorigenic overexpression of stathmin/Op18 by
gain-of-function mutation in p53 in human hepatocarcinogenesis.
Hepatology 2007, 46:759–768.
15. Yuan RH, Jeng YM, Chen HL, Lai PL, Pan HW, Hsieh FJ, Lin CY, Lee PH, Hsu
HC: Stathmin overexpression cooperates with p53 mutation and
osteopontin overexpression, and is associated with tumour progression,
early recurrence, and poor prognosis in hepatocellular carcinoma.
J Pathol 2006, 209:549–558.
16. Lamberti A, Caraglia M, Longo O, Marra M, Abbruzzese A, Arcari P: The
translation elongation factor 1A in tumorigenesis, signal transduction
and apoptosis: review article. Amino Acids 2004, 26:443–448.
17. Edmonds BT, Wyckoff J, Yeung YG, Wang Y, Stanley ER, Jones J, Segall J,
Condeelis J: Elongation factor-1 alpha is an overexpressed actin binding
protein in metastatic rat mammary adenocarcinoma. J Cell Sci 1996,
109(Pt 11):2705–2714.
18. Pecorari L, Marin O, Silvestri C, Candini O, Rossi E, Guerzoni C, Cattelani S,
Mariani SA, Corradini F, Ferrari-Amorotti G, Cortesi L, Bussolari R, Raschella G,
Ahn et al. Journal of Translational Medicine 2014, 12:154 Page 12 of 12
http://www.translational-medicine.com/content/12/1/154Federico MR, Calabretta B: Elongation Factor 1 alpha interacts with
phospho-Akt in breast cancer cells and regulates their proliferation,
survival and motility. Mol Cancer 2009, 8:58.
19. Grassi G, Scaggiante B, Farra R, Dapas B, Agostini F, Baiz D, Rosso N, Tiribelli
C: The expression levels of the translational factors eEF1A 1/2 correlate
with cell growth but not apoptosis in hepatocellular carcinoma cell lines
with different differentiation grade. Biochimie 2007, 89:1544–1552.
20. Edmondson HA, Steiner PE: Primary carcinoma of the liver: a study of 100
cases among 48,900 necropsies. Cancer 1954, 7:462–503.
21. Holmfeldt P, Sellin ME, Gullberg M: Upregulated Op18/stathmin activity
causes chromosomal instability through a mechanism that evades the
spindle assembly checkpoint. Exp Cell Res 2010, 316:2017–2026.
22. Zhang Y, Fujita N, Tsuruo T: Caspase-mediated cleavage of p21Waf1/Cip1
converts cancer cells from growth arrest to undergoing apoptosis.
Oncogene 1999, 18:1131–1138.
doi:10.1186/1479-5876-12-154
Cite this article as: Ahn et al.: Increased expression of stathmin and
elongation factor 1α in precancerous nodules with telomere
dysfunction in hepatitis B viral cirrhotic patients. Journal of Translational
Medicine 2014 12:154.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
